Log in to save to my catalogue

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic li...

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic li...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6675411

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

About this item

Full title

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

Publisher

New Delhi: Springer India

Journal title

Hepatology international, 2019-01, Vol.13 (1), p.84-90

Language

English

Formats

Publication information

Publisher

New Delhi: Springer India

More information

Scope and Contents

Contents

Background and aims
While the association between platelet activation and hepatic fibrosis has been previously demonstrated in animal studies; the utility of anti-platelet agents in reversing the progression of hepatic fibrosis requires further review. Utilizing systematic review methods, we provide to our knowledge the first meta-analysis combi...

Alternative Titles

Full title

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6675411

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6675411

Other Identifiers

ISSN

1936-0533

E-ISSN

1936-0541

DOI

10.1007/s12072-018-9918-2

How to access this item